CSIMarket
 
Vicarious Surgical Inc   (RBOT)
Other Ticker:  
 
 
Price: $0.3827 $0.06 17.213%
Day's High: $0.3827 Week Perf: 10.9 %
Day's Low: $ 0.32 30 Day Perf: 1.7 %
Volume (M): 986 52 Wk High: $ 2.47
Volume (M$): $ 377 52 Wk Avg: $1.10
Open: $0.32 52 Wk Low: $0.20



 Market Capitalization (Millions $) 60
 Shares Outstanding (Millions) 157
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -69
 Cash Flow (TTM) (Millions $) -68
 Capital Exp. (TTM) (Millions $) 2

Vicarious Surgical Inc
Vicarious Surgical Inc is a Silicon Valley-based robotic surgery company. It specializes in developing and manufacturing robotic surgical systems that aim to improve the precision and outcomes of minimally invasive surgical procedures. The company's technology combines virtual reality, artificial intelligence, and advanced robotics to provide surgeons with a more intuitive and immersive way to perform complex surgeries. Vicarious Surgical's mission is to make robotic surgery accessible and affordable, ultimately transforming the way surgical procedures are conducted worldwide.


   Company Address: 78 Fourth Avenue Waltham 2451 MA
   Company Phone Number: 868-1700   Stock Exchange / Ticker: NYSE RBOT
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Management Changes

Vicarious Surgical Appoints Randy Clark as President, Aims to Revitalize Financial Performance and Drive Growth in Robotics-Assisted Surgery.

Published Mon, Jan 29 2024 1:30 PM UTC

Vicarious Surgical Strengthens Executive Team with Appointment of Randy Clark as Company President
Vicarious Surgical Inc., a leading robotics technology company focused on enhancing patient outcomes and improving the cost and efficiency of surgical procedures, has announced the appointment of Randy Clark as its new President. The appointment, effective from January 29, ...

Vicarious Surgical Inc

Vicarious Surgical Inc. Defies Expectations with Reduced Operating Losses Despite Challenging Quarter

Vicarious Surgical Inc. Reports Moderate Top-Line Moderations and Decreased Operating Losses
Vicarious Surgical Inc., a next-generation robotics technology company, recently announced its financial results for the quarter ended September 30, 2023. While the results indicate some moderations at the top-line, the company has managed to reduce its operating losses compared to previous quarters, reflecting its efforts to improve cost-effectiveness and business strategy.
During the quarter, the company's operating loss came in at $-21.352 million, which represents a slight improvement compared to the operating loss of $-22.162 million in the third quarter of 2022. This is a significant indicator of the company's condition and highlights its commitment to curbing losses and improving its financial outlook.

Vicarious Surgical Inc

Vicarious Surgical Inc Records Second Quarter Operating Loss Amid 2023 Reporting Season for Biotechnology & Pharmaceuticals Sector

Vicarious Surgical Inc, a leading player in the Biotechnology & Pharmaceuticals sector, recently announced its operating loss for the fiscal span closing June 30, 2023. With an operating loss of $-21.458 million, the company is clearly facing some challenges. However, it is important to examine the broader context and recent efforts to gain a better understanding of their performance.
Though the top-line figures have not been disclosed yet, comparing the operating loss with that of the second quarter of 2022 ($-19.126 million) shows that Vicarious Surgical Inc is making progress. The management team has implemented distinct financial plans to secure steady revenue sources, indicating their commitment to improve the company's financial standing.

Vicarious Surgical Inc

Operating Losses Soar at RBOT in First Quarter of 2023, Raising Concerns for Vicarious Surgical Inc's Financial Health

The Biotechnology & Pharmaceuticals industry consultants have been closely monitoring the performance of Vicarious Surgical Inc and the results for the first quarter of 2023 are not looking good. The operating loss of $-22.315 million is certainly concerning, particularly given that there has been no mention of any top-line figures.
While it is understandable that a growing company like Vicarious Surgical Inc may not yet have significant revenues, it is worrying that there has been no disclosure of top-line figures. This lack of transparency could signal deeper issues within the company and leave investors questioning the overall health of the business.






 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com